The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients

OBJECTIVE: To determine whether drospirenone/estradiol (DRSP/E2) has an adverse effect on clinical outcomes in surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I/II endometrial cancer (EC) patients. METHODS: In a retrospective case-controlled study, 58 women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Soyi, Kim, Yun Hwan, Lee, Kwang-Beom, Lee, Jong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078887/
https://www.ncbi.nlm.nih.gov/pubmed/30022635
http://dx.doi.org/10.3802/jgo.2018.29.e72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078887/
https://www.ncbi.nlm.nih.gov/pubmed/30022635
http://dx.doi.org/10.3802/jgo.2018.29.e72

Ejemplares similares